Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1279 of 5804
-
Poking skin to bring back color: which needle works best for vitiligo?
Disease control Recruiting nowThis randomized controlled trial aims to compare the efficacy of needling versus microneedling, both followed by narrowband UVB therapy, in achieving repigmentation in patients with localized stable non-segmental vitiligo.
Phase: PHASE4 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:18 UTC
-
Uterine scarring breakthrough? 5,000-Woman study tests new surgery and stent
Disease control Recruiting nowThis research plan aims to explore a new diagnosis and treatment management model for intrauterine adhesions and verify its efficacy and feasibility through a multicenter real-world study. Intrauterine adhesions are a common gynecological disease that may affect women's fertility…
Phase: NA • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Experimental Cell-Drug combo takes on tough leukemia
Disease control OngoingPhase I, open-label study to assess the safety, feasibility, pharmacokinetics, and preliminary efficacy of CART123 cells given in combination with ruxolitinib in patients with relapsed or refractory acute myeloid leukemia (AML). All subjects will receive a single infusion of CART…
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
HS patients who responded to drug get extended access in new study
Disease control Recruiting nowRollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New immune drug targets common cancer mutation in early trial
Disease control Recruiting nowPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.
Phase: PHASE1 • Sponsor: Clasp Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New combo aims to free myelofibrosis patients from frequent blood transfusions
Disease control Recruiting nowThe purpose of this Phase 2 study is to evaluate the efficacy and safety of momelotinib (MMB) in combination with luspatercept (LUSPA) in participants with transfusion dependence (TD) primary myelofibrosis (PMF) or Post-polycythemia vera (PV)/ essential thrombocythemia (ET) myelo…
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Glowing dye during surgery could prevent dangerous throat leaks
Disease control Recruiting nowInvestigators performing this research want to look at the use of a special imaging process during a specific throat surgery. Using this imaging may help to lower a common complication that called a pharyngocutaneous fistula (PCF). A PCF is a leak in the tube in the throat that h…
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Can a Follow-Up drug deepen remission in myeloma patients?
Disease control OngoingThis study is designed to evaluate if treatment with adjuvant nivolumab improves depth of response in patients with relapsed refractory multiple myeloma (RRMM) who achieve a less-than-ideal response to idecaptagene vicleucel.
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Poo test could spare thousands from unpleasant camera exams
Diagnosis Recruiting nowIn the United Kingdom, over 25,000 patients have an operation for bowel cancer each year. After their operation, patients are monitored with a colonoscopy (camera test of the bowel) approximately 3 years after their operation, to look for any possible return of the cancer. Colono…
Sponsor: Nottingham University Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Heart CT Follow-Up could cut heart attacks in Non-Obstructive disease
Disease control Recruiting nowThe primary objective of this study is to evaluate whether a management strategy based on coronary computed tomography angiography (CCTA) for patients with non-obstructive coronary artery disease can improve the LDL-C target achievement rate compared to a traditional management s…
Phase: NA • Sponsor: Zhang longjiang,MD • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a shot stop mouth cancer before it starts?
Disease control Recruiting nowTo evaluate the antitumor efficacy of intralesional injections of nivolumab in patients with high-risk oral premalignant lesions
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug combo targets tough lung cancer mutation
Disease control Recruiting nowThe purpose of this study is to establish the recommended phase 2 dose (RP2D), safety, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antitumor activity of ORIC-114 in combination with subcutaneous (SC) amivantamab in patients with advanced or metastatic NSCLC harb…
Phase: PHASE1 • Sponsor: ORIC Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a Cannabis-Derived drug help COPD patients breathe easier?
Symptom relief Recruiting nowThis clinical trial examines whether Dronabinol, which contains the synthetic psychoactive compound tetrahydrocannabinol (THC), can alleviate severe breathlessness in patients with severe and very severe chronic obstructive pulmonary disease (COPD).
Phase: PHASE3 • Sponsor: Vejle Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Can art and meditation heal shame in abused teens?
Symptom relief CompletedAdolescence is an important stage of development when many mental health difficulties first appear. Young people who have experienced abuse are especially vulnerable, as abuse can lead to intense feelings of shame and negatively affect their body self-concept. This study explored…
Phase: NA • Sponsor: Ardakan University • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New Antibody-Drug conjugate enters human trials for advanced cancers
Disease control Recruiting nowIM-1021-101 is a Phase 1 study to determine the safety and effectiveness of IM-1021 in treating participants with advanced cancer.
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New injection aims to tame dangerous pregnancy condition
Disease control Recruiting nowThis study is a dose finding study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of subcutaneous CBP-4888 in hospitalized participants with Preterm Preeclampsia receiving Standard of Care, Expectant Management. Eligible participants are between 26 +…
Phase: PHASE1 • Sponsor: Comanche Biopharma • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
One-Shot gene therapy could ease knee arthritis pain for years
Symptom relief OngoingThe goal of this clinical trial is to learn if a single knee injection of different doses (Dose A and Dose B) of an investigation product PCRX-201, following steroid pretreatment, is safe and tolerable in male of female patients 45 to 80 years old with osteoarthritis of the knee.…
Phase: PHASE2 • Sponsor: Pacira Pharmaceuticals, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Smart dosing of immunotherapy combo shows promise for kidney cancer
Disease control TerminatedThis is a Phase II Clinical Trial that will evaluate the use of adaptive dosing of pembro-axi in patients with Metastatic Clear Cell Renal Cell Carcinoma (mccRCC).
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New pill shows promise for rare hormone disorder in Long-Term trial
Disease control Recruiting nowThe purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of atumelnant (CRN04894).
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
ER docs get a suicide risk score: will it save lives?
Knowledge-focused Recruiting nowThe primary aim of this project are to evaluate a comprehensive, practice-ready, and deployment-focused strategy for improving the prediction and prevention of suicide attempts among a sample of 4,000 patients presenting to an ED with a psychiatric concern. The first aim is to ev…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC